Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zai Lab (ZLAB) Change in Receivables (2020 - 2025)

Zai Lab's Change in Receivables history spans 6 years, with the latest figure at $19.7 million for Q4 2025.

  • For Q4 2025, Change in Receivables fell 46.42% year-over-year to $19.7 million; the TTM value through Dec 2025 reached $18.9 million, down 29.82%, while the annual FY2025 figure was $18.9 million, 29.82% down from the prior year.
  • Change in Receivables for Q4 2025 was $19.7 million at Zai Lab, up from -$3.7 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $36.7 million in Q4 2024 and bottomed at -$20.6 million in Q3 2024.
  • The 5-year median for Change in Receivables is $3.8 million (2021), against an average of $5.2 million.
  • The largest annual shift saw Change in Receivables skyrocketed 1236.15% in 2021 before it plummeted 757.91% in 2025.
  • A 5-year view of Change in Receivables shows it stood at $26.5 million in 2021, then plummeted by 54.07% to $12.2 million in 2022, then surged by 41.67% to $17.2 million in 2023, then skyrocketed by 113.09% to $36.7 million in 2024, then crashed by 46.42% to $19.7 million in 2025.
  • Per Business Quant, the three most recent readings for ZLAB's Change in Receivables are $19.7 million (Q4 2025), -$3.7 million (Q3 2025), and $11.7 million (Q2 2025).